Abstract: The present invention relates to stable aqueous protein formulations. In particular, disclosed herein are therapeutic protein formulations suitable for parenteral administration having one or more antioxidants.

Abstract: The present invention relates to stable aqueous protein formulations. In particular, disclosed herein are therapeutic protein formulations suitable for parenteral administration having one or more antioxidants.

Abstract: One embodiment provides an apparatus. The apparatus may include memory circuitry to store tensor data representing a tensor. The apparatus may include memory controller circuitry to access the memory circuitry. The apparatus may include processor circuitry to: receive a request for a tensor operation; generate a plurality of sub-commands for the tensor operation; and provide the sub-commands to memory controller circuitry to perform the tensor operation based on instructions contained in one or more of the sub-commands. The instructions contained in one or more of the sub-commands may include identify addresses in memory to access; activate one or more rows in the memory circuitry that correspond to the addresses; and transfer tensor data to and/or from the memory circuitry.

Abstract: Provided herein are compositions and methods for preventing or reducing scar formation (e.g., hypertrophic scars). Certain embodiments provide a method of preventing hypertrophic scar formation in a subject comprising administering a HMG-CoA reductase-inhibiting agent to a wound site. In some embodiments, the wound site comprises scar tissue.

Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from caritine, creatine or creatinine.

Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.

Abstract: A system for facilitating management of chores is disclosed. The system may include a communication device configured for receiving chore data from a parent device, transmitting the chore data to a child device, receiving operational data from at least one electrical appliance associated with the chore data, transmitting chore status data corresponding to the at least one chore to the parent device, and transmitting account data corresponding to at least one child account to the child device. Further, the system may include a processing device configured for analyzing the chore data and the operational data, generating the chore status data based on the analyzing, determining at least one reward based on the chore status data, and updating the account data based on the at least one reward. Further, the system may include a storage device configured for storing the chore data, the chore status data and the account data.

Abstract: One embodiment provides an apparatus. The apparatus may include memory circuitry to store tensor data representing a tensor. The apparatus may include memory controller circuitry to access the memory circuitry. The apparatus may include processor circuitry to: receive a request for a tensor operation; generate a plurality of sub-commands for the tensor operation; and provide the sub-commands to memory controller circuitry to perform the tensor operation based on instructions contained in one or more of the sub-commands. The instructions contained in one or more of the sub-commands may include identify addresses in memory to access; activate one or more rows in the memory circuitry that correspond to the addresses; and transfer tensor data to and/or from the memory circuitry.

Abstract: Provided herein are compositions and methods for preventing or reducing scar formation (e.g., hypertrophic scars). Certain embodiments provide a method of preventing hypertrophic scar formation in a subject comprising administering a HMG-CoA reductase-inhibiting agent to a wound site. In some embodiments, the wound site comprises scar tissue.

Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.

Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.

Abstract: The present invention relates to stable aqueous protein formulations. In particular, disclosed herein are therapeutic protein formulations suitable for parenteral administration having one or more antioxidants.

Abstract: The present invention relates to stable aqueous protein formulations. In particular, disclosed herein are therapeutic protein formulations suitable for parenteral administration having one or more antioxidants.

Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.

Abstract: Provided herein are compositions and methods for preventing or reducing scar formation (e.g., hypertrophic scars). For example, provided herein are methods of administrating HMG-CoA-inhibiting agents for preventing or reducing scar formation.

Abstract: The present invention relates to stable aqueous protein formulations. In particular, disclosed herein are therapeutic protein formulations suitable for parenteral administration having one or more antioxidants.

Abstract: A stable pharmaceutical formulation is provided that comprises a biologically active protein and an excipient selected from carnitine, creatine or creatinine.

Abstract: A two-stage method of preparing essentially pure amino acid chelates, wherein the first stage comprises contacting a metal ion from a metal oxide or hydroxide with an amino acid thereby producing a metal hydroxyl amino acetate. The second stage comprises contacting the metal hydroxyl amino acetate from the first stage, with at least one amino-containing compound provided in excess thereby producing a reaction solution containing an amino acid chelate reaction product comprising a metal ion bound to a plurality of amino acid ligands wherein the plurality of amino acid ligands is equal to the coordination number of the metal ion, and then separating the amino acid chelate from the reaction solution. The second stage may include a plurality of steps for sequentially reacting the reaction product with a plurality of amino-containing compounds. The amino acid chelates thus produced can be incorporated into compositions comprising beverages, foodstuffs, nutraceuticals and pharmaceutical adjuvants.

Abstract: A conducting roller assembly for an electroplating apparatus includes two conducting rollers arranged one above another so as to clamp and move a plate-shaped workpiece therebetween. The rollers are disposed intimately over one of two conducting members, and under the other one of the members. Each of the members is connected to two opposite sides of the respective one of the rollers by means of two horizontal rows of equidistant conducting posts. Each of the posts has one end that is fixed to and that is in electrical connection with a respective one of the members, and another end that is biased to contact the respective one of the rollers so as to establish an electrical connection between the respective one of the members and the respective one of the rollers.

Abstract: A roller assembly for an electroplating apparatus includes a plurality of feeding rollers adapted to advance a sheet-shaped workpiece, and a threaded rod disposed parallel to the feeding rollers and having a left-hand thread portion and a right-hand thread portion. Two guiding members are respectively formed with two threaded holes, which engage the left-hand and right-hand thread portions of the rod. A sensing unit detects the width of the workpiece to activate a controller and a driving unit, which rotates the rod so as to move the guiding members in opposite directions such that the guiding members abut against two opposite sides of the workpiece, thereby guiding the workpiece to move therebetween. Two conducting units are attached respectively to the guiding members for supplying cathode current to the sides of the workpiece.